UnitedHealth Group Inc (NYSE:UNH) is Raub Brock Capital Management LP’s 8th Largest Position

Raub Brock Capital Management LP grew its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.7% in the 4th quarter, HoldingsChannel reports. The firm owned 86,594 shares of the healthcare conglomerate’s stock after acquiring an additional 2,291 shares during the quarter. UnitedHealth Group makes up about 4.5% of Raub Brock Capital Management LP’s portfolio, making the stock its 8th biggest position. Raub Brock Capital Management LP’s holdings in UnitedHealth Group were worth $25,457,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. IHT Wealth Management LLC lifted its stake in UnitedHealth Group by 28.9% in the 3rd quarter. IHT Wealth Management LLC now owns 3,671 shares of the healthcare conglomerate’s stock worth $816,000 after acquiring an additional 822 shares in the last quarter. Nomura Holdings Inc. raised its stake in shares of UnitedHealth Group by 474.5% during the 3rd quarter. Nomura Holdings Inc. now owns 561,936 shares of the healthcare conglomerate’s stock worth $122,846,000 after purchasing an additional 464,121 shares in the last quarter. Penserra Capital Management LLC raised its stake in shares of UnitedHealth Group by 40.4% during the 3rd quarter. Penserra Capital Management LLC now owns 3,915 shares of the healthcare conglomerate’s stock worth $849,000 after purchasing an additional 1,126 shares in the last quarter. D.A. Davidson & CO. raised its stake in shares of UnitedHealth Group by 5.6% during the 3rd quarter. D.A. Davidson & CO. now owns 42,996 shares of the healthcare conglomerate’s stock worth $9,344,000 after purchasing an additional 2,264 shares in the last quarter. Finally, Grimes & Company Inc. raised its stake in shares of UnitedHealth Group by 1.5% during the 3rd quarter. Grimes & Company Inc. now owns 31,339 shares of the healthcare conglomerate’s stock worth $6,811,000 after purchasing an additional 461 shares in the last quarter. 85.81% of the stock is owned by institutional investors and hedge funds.

A number of equities research analysts have recently weighed in on the company. Mizuho reaffirmed a “buy” rating and set a $300.00 price target (up from $270.00) on shares of UnitedHealth Group in a research note on Tuesday, November 26th. Stephens raised their price target on UnitedHealth Group from $325.00 to $333.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 15th. Morgan Stanley reaffirmed a “buy” rating and set a $312.00 price target (up from $294.00) on shares of UnitedHealth Group in a research note on Friday, November 22nd. JPMorgan Chase & Co. raised their price target on UnitedHealth Group from $276.00 to $361.00 and gave the stock an “overweight” rating in a research note on Friday, December 20th. Finally, Oppenheimer raised their price target on UnitedHealth Group from $312.00 to $343.00 and gave the stock an “outperform” rating in a research note on Thursday, January 16th. Five investment analysts have rated the stock with a hold rating and nineteen have given a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $313.50.

Shares of NYSE UNH opened at $280.84 on Monday. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.70 and a current ratio of 0.69. The firm has a market cap of $277.41 billion, a price-to-earnings ratio of 19.60, a P/E/G ratio of 1.44 and a beta of 0.65. The business’s 50-day simple moving average is $291.83 and its 200-day simple moving average is $257.46. UnitedHealth Group Inc has a 52 week low of $208.07 and a 52 week high of $302.54.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Wednesday, January 15th. The healthcare conglomerate reported $3.90 EPS for the quarter, beating the Zacks’ consensus estimate of $3.77 by $0.13. The business had revenue of $60.90 billion for the quarter, compared to analyst estimates of $61.17 billion. UnitedHealth Group had a return on equity of 25.55% and a net margin of 5.71%. The firm’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.28 EPS. As a group, equities research analysts forecast that UnitedHealth Group Inc will post 16.47 earnings per share for the current year.

In other UnitedHealth Group news, CAO Thomas E. Roos sold 1,177 shares of the firm’s stock in a transaction that occurred on Thursday, November 7th. The stock was sold at an average price of $255.04, for a total value of $300,182.08. Following the sale, the chief accounting officer now owns 21,687 shares of the company’s stock, valued at approximately $5,531,052.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 16th. The shares were sold at an average price of $299.45, for a total value of $4,491,750.00. Following the completion of the sale, the director now directly owns 158,598 shares in the company, valued at approximately $47,492,171.10. The disclosure for this sale can be found here. In the last three months, insiders have sold 23,577 shares of company stock worth $6,810,430. 0.82% of the stock is currently owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Read More: What is the Dividend Aristocrat Index?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.